- Home
- BCRX vs ATEN Comparison
BCRX vs ATEN Comparison
Compare BCRX & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- ATEN
- Stock Information
- Founded
- BCRX 1986
- ATEN 2004
- Country
- BCRX United States
- ATEN United States
- Employees
- BCRX N/A
- ATEN N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- ATEN EDP Services
- Sector
- BCRX Health Care
- ATEN Technology
- Exchange
- BCRX Nasdaq
- ATEN Nasdaq
- Market Cap
- BCRX 1.7B
- ATEN 1.5B
- IPO Year
- BCRX 1994
- ATEN 2014
- Fundamental
- Price
- BCRX $7.40
- ATEN $15.75
- Analyst Decision
- BCRX Buy
- ATEN Buy
- Analyst Count
- BCRX 6
- ATEN 2
- Target Price
- BCRX $15.67
- ATEN $21.00
- AVG Volume (30 Days)
- BCRX 3.2M
- ATEN 1.2M
- Earning Date
- BCRX 05-05-2025
- ATEN 05-01-2025
- Dividend Yield
- BCRX N/A
- ATEN 1.53%
- EPS Growth
- BCRX N/A
- ATEN 26.41
- EPS
- BCRX N/A
- ATEN 0.67
- Revenue
- BCRX $450,712,000.00
- ATEN $261,696,000.00
- Revenue This Year
- BCRX $27.64
- ATEN $9.23
- Revenue Next Year
- BCRX $13.42
- ATEN $7.49
- P/E Ratio
- BCRX N/A
- ATEN $23.51
- Revenue Growth
- BCRX 36.00
- ATEN 3.97
- 52 Week Low
- BCRX $4.03
- ATEN $12.27
- 52 Week High
- BCRX $9.50
- ATEN $21.90
- Technical
- Relative Strength Index (RSI)
- BCRX 50.46
- ATEN 40.39
- Support Level
- BCRX $6.02
- ATEN $15.40
- Resistance Level
- BCRX $7.41
- ATEN $16.23
- Average True Range (ATR)
- BCRX 0.44
- ATEN 0.76
- MACD
- BCRX 0.06
- ATEN 0.10
- Stochastic Oscillator
- BCRX 81.66
- ATEN 62.78
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ATEN A10 Networks Inc.
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.